Literature DB >> 5357744

The effect of ascorbic acid deficiency on desferrioxamine-induced urinary iron excretion.

A A Wapnick, S R Lynch, R W Charlton, H C Seftel, T H Bothwell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5357744     DOI: 10.1111/j.1365-2141.1969.tb01407.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  Iron absorption and distribution in normal and scorbutic guinea pigs.

Authors:  J M Glover; P R Jones; D A Greenman; R E Hughes; A Jacobs
Journal:  Br J Exp Pathol       Date:  1972-06

3.  Storage iron and desferrioxamine.

Authors:  J Fielding
Journal:  Proc R Soc Med       Date:  1970-12

Review 4.  Current concepts in the management of thalassemia.

Authors:  R S Festa
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

5.  Ascorbic acid status in iron-deficiency anaemia.

Authors:  A Jacobs; D Greenman; E Owen; I Cavill
Journal:  J Clin Pathol       Date:  1971-11       Impact factor: 3.411

6.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04

7.  Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.

Authors:  G E Janka; P Möhring; M Helmig; R J Haas; K Betke
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

8.  Hemochromatosis caused by excessive vitamin iron intake.

Authors:  G R Hennigar; W B Greene; E M Walker; C de Saussure
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.